Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0229353dc0ef6d70d96e6bb2cea7cd40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eea334a28ca9f24c64cc0631e45b4bea |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-241 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-55 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55 |
filingDate |
2022-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0dcea7eb2a4c6dac00a3ddd959ab0ac0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08346ab614f3f22d6765e08203d85a68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd34a499e9120f4a3789bf3018e1f4e9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a07050ed4da54b69b34d80f72e19f1b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a65dfef76234f7b7ef4b0623fb661d89 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5dacf2ab1563f94ec00fcc1eac36dbdc |
publicationDate |
2022-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2022152856-A1 |
titleOfInvention |
Methods and compositions for treating ischaemia in a subject |
abstract |
The present application refers to alpha-1 antitrypsin for use in combined therapy for the treatment of ischaemia, wherein the combined therapy comprises the simultaneous, sequential or separate administration within a therapeutic interval of alpha-1 antitrypsin and a tumor necrosis factor alpha inhibitor. |
priorityDate |
2021-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |